FDA Inspection
Cerovene Inc.Cerovene Inc. – FDA Inspection, Feb 8, 2017
Record Details
This FDA Inspection record concerns Cerovene Inc., with an inspection on February 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · afe846b8-4499-4b93-bb15-856205fe84e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1001439
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cerovene Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2026 | Not classified | New York District Office | |
| April 28, 2025 | VAI | New York District Office | Generic Drug Evaluation |
| August 1, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2017 | Not classified | New York District Office |
Other documents for Cerovene Inc.
- FDA Inspection 1308838 - 2026-03-23
- FDA Inspection 1269142 - 2025-04-28
- FDA Inspection 1215341 - 2023-08-01
- FDA Inspection 1074159 - 2018-11-05
- FDA Inspection 1030876 - 2017-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.